Skip to content
Back to ZURA

Zura Bio Ltd

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
1
Purchases
1
Sales
0
Purchase value
$12.50M
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Access Industries Holdings LLC10% owner
Access Industries Management, LLC10% owner
AI Biotechnology LLC10% owner
Blavatnik Len10% owner
4
Filed Mar 2, 2026Period of report Feb 26, 20260001193125-26-085900
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseFeb 26, 2026
Class A Ordinary SharesF1F22,000,000$6.25$12.50M6,552,725Direct
Filing footnotes · 2
  1. F1Shares of Class A Ordinary Shares acquired pursuant to a registered offering of Class A Ordinary Shares by the Issuer.
  2. F2The securities reported are held directly by AI Biotechnology LLC ("AIB") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.